Literature DB >> 12627217

A Nod Scid mouse model to study human prostate cancer.

C Bastide1, C Bagnis, P Mannoni, J Hassoun, F Bladou.   

Abstract

Prostate cancer is the second cause of cancer mortality in men in Western countries. To study new therapeutic approaches such as gene therapy, animal models of human prostate cancer with metastatic behavior are mandatory. We used the Nod Scid mouse strain to develop an orthotopic animal model. Two androgen-independent cell lines (PC-3 and DU 145) were used. Local tumor growth and metastases were analyzed. The tumor take rates were close to those reported in the literature. However, a high frequency of various metastatic sites has been observed (liver, lung, spleen, adrenal, kidney, lymph node, and diaphragm). It can be concluded that the Nod Scid mouse is a relevant preclinical animal model to study human prostate cancer. Metastatic sites seem more numerous in comparison to other orthotopic mice models described.

Entities:  

Mesh:

Year:  2002        PMID: 12627217     DOI: 10.1038/sj.pcan.4500606

Source DB:  PubMed          Journal:  Prostate Cancer Prostatic Dis        ISSN: 1365-7852            Impact factor:   5.554


  22 in total

1.  Matrix metalloproteinase activity and osteoclasts in experimental prostate cancer bone metastasis tissue.

Authors:  Zhong Dong; R Daniel Bonfil; Sreenivasa Chinni; Xiyun Deng; J Carlos Trindade Filho; Margarida Bernardo; Ulka Vaishampayan; Mingxin Che; Bonnie F Sloane; Shijie Sheng; Rafael Fridman; Michael L Cher
Journal:  Am J Pathol       Date:  2005-04       Impact factor: 4.307

2.  Oncogenic Role of the Ec Peptide of the IGF-1Ec Isoform in Prostate Cancer.

Authors:  Athanasios Armakolas; Maria Kaparelou; Andreas Dimakakos; Efstathia Papageorgiou; Nikolaos Armakolas; Athanasios Antonopoulos; Constantina Petraki; Maria Lekarakou; Pavlos Lelovas; Martha Stathaki; Constantinos Psarros; Ismene Donta; Panos S Galanos; Paul Msaouel; Vassilis G Gorgoulis; Michael Koutsilieris
Journal:  Mol Med       Date:  2015-01-06       Impact factor: 6.354

Review 3.  Meganucleases Revolutionize the Production of Genetically Engineered Pigs for the Study of Human Diseases.

Authors:  Bethany K Redel; Randall S Prather
Journal:  Toxicol Pathol       Date:  2015-10-28       Impact factor: 1.902

4.  In vitro and in vivo model systems used in prostate cancer research.

Authors:  David Cunningham; Zongbing You
Journal:  J Biol Methods       Date:  2015

5.  Pten loss and RAS/MAPK activation cooperate to promote EMT and metastasis initiated from prostate cancer stem/progenitor cells.

Authors:  David J Mulholland; Naoko Kobayashi; Marcus Ruscetti; Allen Zhi; Linh M Tran; Jiaoti Huang; Martin Gleave; Hong Wu
Journal:  Cancer Res       Date:  2012-02-20       Impact factor: 12.701

6.  GLS2 is protumorigenic in breast cancers.

Authors:  Marilia M Dias; Douglas Adamoski; Larissa M Dos Reis; Carolline F R Ascenção; Andre Luis Berteli Ambrosio; Sandra Martha Gomes Dias; Krishina R S de Oliveira; Ana Carolina Paschoalini Mafra; Alliny Cristiny da Silva Bastos; Melissa Quintero; Carolina de G Cassago; Igor M Ferreira; Carlos H V Fidelis; Silvana A Rocco; Marcio Chaim Bajgelman; Zachary Stine; Ioana Berindan-Neagoe; George A Calin
Journal:  Oncogene       Date:  2019-09-20       Impact factor: 9.867

7.  Decreased adhesiveness, resistance to anoikis and suppression of GRP94 are integral to the survival of circulating tumor cells in prostate cancer.

Authors:  Edward W Howard; Steve C L Leung; H F Yuen; Chee Wai Chua; Davy T Lee; K W Chan; Xianghong Wang; Yong Chuan Wong
Journal:  Clin Exp Metastasis       Date:  2008-03-14       Impact factor: 5.150

8.  TRAIL-coated leukocytes that prevent the bloodborne metastasis of prostate cancer.

Authors:  Elizabeth C Wayne; Siddarth Chandrasekaran; Michael J Mitchell; Maxine F Chan; Rachel E Lee; Chris B Schaffer; Michael R King
Journal:  J Control Release       Date:  2015-12-28       Impact factor: 9.776

9.  Endoscopy-guided orthotopic implantation of colorectal cancer cells results in metastatic colorectal cancer in mice.

Authors:  Dominik Bettenworth; Marcus M Mücke; Katrin Schwegmann; Andreas Faust; Christopher Poremba; Michael Schäfers; Dirk Domagk; Philipp Lenz
Journal:  Clin Exp Metastasis       Date:  2016-05-04       Impact factor: 5.150

10.  Exosomes secreted by prostate cancer cells under hypoxia promote matrix metalloproteinases activity at pre-metastatic niches.

Authors:  Gagan Deep; Anil Jain; Ashish Kumar; Chapla Agarwal; Susy Kim; W Matthew Leevy; Rajesh Agarwal
Journal:  Mol Carcinog       Date:  2020-01-14       Impact factor: 4.784

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.